Company Profile
California Molecular Electronics Corp. (CALMEC®) is a high technology company with a business plan to become the leader in the molecular electronics industry. Founded in March 1997 and incorporated in the State of Arizona, CALMEC's objective is to commercially develop the field of molecular electronics, a new technology frontier. It is based on the principle of using individual molecules to form the components of electronic devices.Molecule-sized electronics produce electronic devices hundreds of times smaller and at a cost lower than that possible with semiconductor electronics. As such, molecular electronics is poised to revolutionize the semiconductor industry, as we know it today.
Research and Development
A vital component to the success of the Company is its Research and Development (R&D) organization. It functions to provide Research, create Intellectual Property, and use such resources for Product Development in the field of molecular electronics. Research probes the new horizons of the molecular electronics technology. It produces Intellectual Property (i.e., trade secrets, patents, etc.) that are, in turn, formed into elements, licensed, and otherwise used for business and commercial applications. Product 
Development functions to produce the technological components and technical processes necessary for the Company to generate and support marketable products. One example of this process is the Company's ownership of rights to the patented Chiropticene® switching technology and its resultant development. This switch is a single molecule that exhibits classical switching properties. One of the many and varied applications envisioned for the Chiropticene molecular switch is in data storage. Using the Chiropticene molecular switch as the central element, CALMEC's R&D organization has developed an architectural concept for a 3-dimensional computer memory device aimed at replacing hard disks, flash memory chips, and computer mass storage media/systems. Initially, this architecture will yield a capacity of 16 terabits (i.e., 2 terabytes or 2 trillion bytes) of data storage in a device the size of a cubic inch providing 34 times the capacity of one of today's 60GB hard drives. Read more about the Chiropticene Switch under Molecular Electronics.
Technical Advisory Committee
CALMEC looks to its Technical Advisory Committee (TAC) for guidance on technical and scientific matters. The TAC functions to:
- Serve as a technical and scientific resource and counsel to the Company's Research and Development organization on various research and development issues such as design alternatives, concepts, practices and procedures.
- Review and advise the Company on the merits or validity of intellectual property that the Company is evaluating and has under consideration. Such intellectual property may have been conceived internally or brought to the Company from outside sources.
The Committee consists of five to nine members with no more than three members being employees of CALMEC at any one time. The remaining members are accomplished individuals from academia and industry who are active in, and share the Company's interest and enthusiasm in, the field of molecular electronics. At present, there are six members on the Committee—one inside and five outside. Jon N. Leonard is the Chairman of the Board and temporarily leads the Committee. Five noted individuals from outside the Company who bring a wealth of scientific knowledge and experience to the group join him on the Committee. They are Dr. Michael P. Cava of the University of Alabama, Dr. Robert M. Metzger of the University of Alabama, Dr. Josef Michl of the University of Colorado, Dr. Mark A. Ratner of Northwestern University, and Dr. Fred Wudl of the University of California, Los Angeles. CALMEC President and CEO James J. Marek, Jr. serves on the Committee in an administrative capacity.
Read more about the committee members under Technical Advisors.
Business Development and Sales
CALMEC's Business Development and Sales organizations are responsible for developing and nurturing the Company's business arrangements and agreements to promote the sale of its products. At present, the Company offers two classes of products: Intellectual Property and Technical Services. The Company markets its Intellectual Property products as joint venture business arrangements. They are licensed, and subsequently supported, to third parties with the Company retaining royalty rights on the sales of any successful products developed from them. Our customers for these products are companies in industries also interested in the future of the molecular electronics technology and, in particular, its applications, such as in the computer, electronics, communications, and chemical industries. In addition, the Company markets its special molecular electronics expertise in the form of Technical Services. Technical Services consist of contract R&D and product development support. The customer base for these services also includes companies in the computer, electronics, communications, and chemical industries.
Plans call for the Company to develop families of hardware and software products through these joint venture arrangements with strategic partners from these industries. These products will consist of molecular electronic devices and the associated, unique operating system software suitable for applications based on these devices.
Management Profile
CALMEC's founders, employees, and major stockholders combine backgrounds in molecular-electronic science, management of high-technology companies, management of startup companies, marketing, sales, and patent development. Its founders are members, or past members, of numerous science, technology, and business associations including: The American Association for the Advancement of Science, the American Chemical Society, and the Council for Entrepreneurial Development.
Dr. Jon N. Leonard, the Company's Chairman, is a consultant to business and government in science, technology, and business development. He was the founding President and CEO of BPM Technology, a company that raised 10 million dollars in venture capital to develop and market a three-dimensional printer product. Prior to that, he was the Chief Scientist of, and responsible for new business development in, the Strategic Products Manufacturing Division of Hughes Aircraft Company. Dr. Leonard has authored numerous technical papers in the areas of electronics, computation, and communication, as well as three popular books in the area of human health. Dr. Leonard received Ph.D. and Bachelor degrees in mathematics and physics from the University of Arizona and a Masters degree in engineering from UCLA.
James J. Marek, Jr., the Company's President and CEO, has 35 years of business experience in high technology companies. He has over 21 years experience in top management positions—CEO, President, General Manager, Vice President of Marketing and Sales, and Director—with full P&L responsibility for start-up companies as well as established multi-million dollar corporations manufacturing and marketing sophisticated electronic products. He has served as a consultant to businesses specializing in startup company management, turnaround restructuring, marketing and sales management, and contract negotiations. Mr. Marek has a Bachelor of Electrical Engineering degree from Marquette University and has performed postgraduate work in Communications, Marketing, Finance, Accounting, and Business Administration.
Dr. Robert R. Schumaker was a co-founder of CALMEC and served as the Company's Executive Vice President of Research and Development. He was born on September 16, 1935 in Redlands, California. While in the position of Senior Laboratory Technician with IBM, he took an educational leave in 1966 to pursue his undergraduate degree in Chemistry at the University of California in Santa Cruz. Two short years later, in 1968, he received his Bachelors Degree with honors in Chemistry. He continued on with his education entering the graduate program at the University of Oregon where, in 1972, he received his Ph.D. in Chemistry. Dr. Schumaker returned to IBM where, as a Senior Research Scientist, he was a leader in molecular electronics research and was credited as the developer of new superconducting materials. In 1978, he took a six month sabbatical from the IBM Research Laboratories in San Jose, California to do work on the synthesis of organic conductors at the IBM Laboratories in Yorktown Heights, New York. While at IBM, Dr. Schumaker received 12 awards for his research including four "Invention Achievement" and three "Special Activities" awards. In 1985, he left industry and spent the next 10 years in research and teaching at the University of Bordeaux in France, the University of Alabama, and the Universidad Autonoma de Guadalajara, the largest private university in Mexico. At the University of Bordeaux, Dr. Schumaker was a Visiting Chief Investigator working on organic semiconductors. While in Europe, he was consultant to several industrial companies. In 1986, Dr. Schumaker returned to the United States joining the Chemistry Department at the University of Alabama in the position of Visiting Scientist working on the synthesis of organic semiconductors. From 1988 through 1992, Dr. Schumaker was on the staff of the Department of Organic Chemistry at the Universidad Autonoma de Guadalajara, during which time he held the position of Professor/Investigator and served as a Ph.D. Program Advisor. In 1992, Dr. Schumaker founded International Molecular Processors, a private company conducting research in the area of molecular switch devices. He holds more than a dozen United States patents including a patent, licensed to the Company, in molecular electronics involving molecular-optical switching.
Dr. Schumaker wrote and co-authored over 33 articles published in such noted publications as the Journal of the American Chemical Society, the Journal of Organic Chemistry, and Solid State Communications. He was invited and presented numerous papers at international scientific meetings such as the Universidad Nacional Autonoma de Mexico Winter Meeting, the American Chemical Society's National Meeting, the Chemical Society of Japan Symposium, and the Academy of Sciences Conference. He prepared and presented over 35 research seminars at Universities, Institutes, and Research Laboratories in seven countries.
Dr. Schumaker was a renowned chemist, inventor, and a very special human being.
Dr. David W. Collins, the Company's Corporate Patent Counsel, has extensive experience in the development of intellectual property in technology fields important to molecular electronics. He has 26 years experience prosecuting patents in the areas of molecular electronics, semiconductors, lasers, photonics, neural network devices, holography, electro-optical devices, quantum well devices, optical fibers, ink-jet technology, chemistry, polymers, ceramics, metallurgy, batteries, fuel cells, and light biotechnology. His clients have included AMD, Cal Tech, Hewlett-Packard, Hughes Electronics, IBM, the Jet Propulsion Laboratories, Sigma Labs, and the University of Southern California. He has a Ph.D. in Solid State Science from Penn State and a Juris Doctorate from Seton Hall. He has bar memberships in the U.S. Patent Office, the California District Court, and the 9th District Court of Appeals among others.
Tom Cellucci is an accomplished serial entrepreneur, seasoned senior executive and Board member possessing extensive corporate and VC experience across a number of worldwide industries. Profitably growing high technology firms at the start-up, mid-range and large corporate level has been his trademark. He also founded in 1999 a highly successful management consulting firm — Cellucci Associates, Inc. — that raises capital and provides strategic business services to top-tier global high technology firms. He serves on both public and private Boards and has authored or co-authored over 120 articles on Nanotechnology, Laser physics, Photonics, Environmental disturbance control, MEMS test and measurement, Mistake-proofing enterprise software, and Sales & Marketing. He has also held the rank of Lecturer or Professor at institutions like Princeton University, University of Pennsylvania and Camden Community College. Cellucci also co-authored ANSI Standard Z136.5 “The Safe Use of Lasers in Educational Institutions”. Cellucci accepted in July 2007 a special five year appointment from the Department of Homeland Security as its Chief Commercialization Officer in the Science and Technology Directorate, responsible for the cost-effective and efficient development of new products and services for the seven Operating Components.
As a result of his consistent achievement in the commercialization of emerging technologies, Cellucci has received numerous awards and citations from industry, government and business. In addition, he has significant experience interacting with high ranking members of the United States government—including the White House, US Senate and US House of Representatives—having provided executive briefs to the President of the United States and ranking members of Congress.
Cellucci earned a PhD in Physical Chemistry from the University of Pennsylvania, an MBA from Rutgers University and a BS in Chemistry from Fordham University. He has also attended and lectured at executive programs at the Harvard Business School, MIT Sloan School, Kellogg School and others. Dr. Cellucci is regarded as an authority in rapid time-to-market new product development and is regularly asked to serve as keynote speaker at both business and technical events.